Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 697,000 | 4,233,000 | 2,418,000 | 2,230,000 | 1,289,000 |
| Depreciation Amortization | 1,936,000 | 8,986,000 | 6,999,000 | 4,089,000 | 2,039,000 |
| Income taxes - deferred | 137,000 | -492,000 | -107,000 | -300,000 | -28,000 |
| Accounts receivable | 87,000 | -1,490,000 | -1,652,000 | -1,496,000 | -1,479,000 |
| Accounts payable and accrued liabilities | -1,594,000 | 951,000 | 1,549,000 | -181,000 | -696,000 |
| Other Working Capital | -1,944,000 | -2,365,000 | -1,889,000 | -3,046,000 | -2,563,000 |
| Other Operating Activity | 4,510,000 | 9,207,000 | 6,494,000 | 5,492,000 | 3,073,000 |
| Operating Cash Flow | $3,829,000 | $19,030,000 | $13,812,000 | $6,788,000 | $1,635,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -265,000 | -1,214,000 | -885,000 | -504,000 | -235,000 |
| Net Acquisitions | -266,000 | -5,441,000 | -4,280,000 | -1,478,000 | -538,000 |
| Purchase Of Investment | N/A | -35,000 | -29,000 | -22,000 | N/A |
| Sale Of Investment | N/A | 76,000 | 42,000 | 39,000 | N/A |
| Other Investing Activity | -43,000 | -29,000 | -28,000 | 49,000 | 38,000 |
| Investing Cash Flow | $-574,000 | $-6,643,000 | $-5,180,000 | $-1,916,000 | $-735,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -499,000 | 5,297,000 | 5,797,000 | 5,556,000 | 1,593,000 |
| Debt Issued | 7,991,000 | 3,994,000 | 3,994,000 | 3,994,000 | 3,994,000 |
| Debt Repayment | N/A | -6,797,000 | -6,789,000 | -6,780,000 | -3,026,000 |
| Common Stock Issued | N/A | 172,000 | 124,000 | 61,000 | N/A |
| Common Stock Repurchased | -1,489,000 | -980,000 | -977,000 | -973,000 | -961,000 |
| Dividend Paid | -3,086,000 | -11,657,000 | -8,746,000 | -5,835,000 | -2,925,000 |
| Other Financing Activity | -1,998,000 | -2,753,000 | -1,961,000 | 9,000 | 67,000 |
| Financing Cash Flow | $919,000 | $-12,724,000 | $-8,558,000 | $-3,968,000 | $-1,258,000 |
| Exchange Rate Effect | -12,000 | 42,000 | 31,000 | 39,000 | 9,000 |
| Beginning Cash Position | 5,229,000 | 5,524,000 | 5,524,000 | 5,524,000 | 5,524,000 |
| End Cash Position | 9,391,000 | 5,229,000 | 5,629,000 | 6,467,000 | 5,175,000 |
| Net Cash Flow | $4,162,000 | $-295,000 | $105,000 | $943,000 | $-349,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,829,000 | 19,030,000 | 13,812,000 | 6,788,000 | 1,635,000 |
| Capital Expenditure | -265,000 | -1,214,000 | -885,000 | -504,000 | -235,000 |
| Free Cash Flow | 3,564,000 | 17,816,000 | 12,927,000 | 6,284,000 | 1,400,000 |